Literature DB >> 9551490

Child and adolescent schizophrenia.

S C Schulz1, R L Findling, A Wise, L Friedman, J Kenny.   

Abstract

Until only very recently, the occurrence of schizophrenia in childhood and early adolescence had been largely neglected. Improved diagnostic formulations have resulted in clarification of the boundaries between childhood schizophrenia, other psychotic disorders, and pervasive developmental disorder. The study of schizophrenia in childhood or adolescence provides a unique opportunity to examine illness characteristics in the absence of the confounds of substance abuse illness, chronicity, and medication effects. Additionally, current etiopathologic models of schizophrenia can be tested in this patient subgroup.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9551490     DOI: 10.1016/s0193-953x(05)70360-9

Source DB:  PubMed          Journal:  Psychiatr Clin North Am        ISSN: 0193-953X


  3 in total

Review 1.  Olanzapine: in adolescents with schizophrenia or bipolar I disorder.

Authors:  Paul L McCormack
Journal:  CNS Drugs       Date:  2010-05       Impact factor: 5.749

2.  Comparing the ability of cognitive and affective Theory of Mind in adolescent onset schizophrenia.

Authors:  Dandan Li; Xiaosi Li; Fengqiong Yu; Xingui Chen; Long Zhang; Dan Li; Qiang Wei; Qing Zhang; Chunyan Zhu; Kai Wang
Journal:  Neuropsychiatr Dis Treat       Date:  2017-03-27       Impact factor: 2.570

3.  Young children with psychotic symptoms and risk for suicidal thoughts and behaviors: a research note.

Authors:  Keneisha Sinclair-McBride; Nicholas Morelli; Sahil Tembulkar; Kelsey Graber; Joseph Gonzalez-Heydrich; Eugene J D'Angelo
Journal:  BMC Res Notes       Date:  2018-08-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.